Cargando…

Advances in influenza vaccination

Influenza virus infections yearly cause high morbidity and mortality burdens in humans, and the development of a new influenza pandemic continues to threaten mankind as a Damoclean sword. Influenza vaccines have been produced by using egg-based virus growth and passaging techniques that were develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reperant, Leslie A., Rimmelzwaan, Guus F., Osterhaus, Albert D.M.E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculty of 1000 Ltd 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047948/ https://www.ncbi.nlm.nih.gov/pubmed/24991424 http://dx.doi.org/10.12703/P6-47

Ejemplares similares

Influenza Vaccines: Successes and Continuing Challenges
por: Becker, Tanja, et al.
Publicado: (2021)

Targets for the Induction of Protective Immunity Against Influenza A Viruses
por: Bodewes, Rogier, et al.
Publicado: (2010)

Age distribution of cases caused by different influenza viruses
por: Rimmelzwaan, Guus F, et al.
Publicado: (2013)

Influenza: from zoonosis to pandemic
por: Reperant, Leslie A., et al.
Publicado: (2016)

COVID-19 vaccination and critical care capacity: Perilous months ahead
por: Reperant, Leslie A., et al.
Publicado: (2021)

Highly Pathogenic Avian Influenza Virus (H5N1) Infection in Red Foxes Fed Infected Bird Carcasses
por: Reperant, Leslie A., et al.
Publicado: (2008)

AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next?
por: Reperant, Leslie A., et al.
Publicado: (2017)

Towards universal influenza vaccines?
por: Osterhaus, Ab, et al.
Publicado: (2011)

Induction of Virus-Specific Cytotoxic T Lymphocytes as a Basis for the Development of Broadly Protective Influenza Vaccines
por: Hillaire, Marine L. B., et al.
Publicado: (2011)

Periodic global One Health threats update
por: Reperant, Leslie A., et al.
Publicado: (2015)

Global task force for influenza
por: Fouchier, Ron, et al.
Publicado: (2005)

Mallards and Highly Pathogenic Avian Influenza Ancestral Viruses, Northern Europe
por: Munster, Vincent J., et al.
Publicado: (2005)

Viral vector-based influenza vaccines
por: de Vries, Rory D., et al.
Publicado: (2016)

Possible Increased Pathogenicity of Pandemic (H1N1) 2009 Influenza Virus upon Reassortment
por: Schrauwen, Eefje J.A., et al.
Publicado: (2011)

Induction of Influenza (H5N8) Antibodies by Modified Vaccinia Virus Ankara H5N1 Vaccine
por: de Vries, Rory D., et al.
Publicado: (2015)

Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus
por: Martina, Byron E., et al.
Publicado: (2008)

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head
por: Wiersma, Lidewij C. M., et al.
Publicado: (2015)

Recurring Influenza B Virus Infections in Seals
por: Bodewes, Rogier, et al.
Publicado: (2013)

Rift Valley Fever Virus—Infection, Pathogenesis and Host Immune Responses
por: Nair, Niranjana, et al.
Publicado: (2023)

Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus–infected mice
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2009)

Linking Influenza Virus Tissue Tropism to Population-Level Reproductive Fitness
por: Reperant, Leslie A., et al.
Publicado: (2012)

Pigs, Poultry, and Pandemic Influenza: How Zoonotic Pathogens Threaten Human Health
por: Kuiken, Thijs, et al.
Publicado: (2011)

Dromedary MERS-CoV replicates in human respiratory tissues
por: Reperant, Leslie A, et al.
Publicado: (2014)

COVID-19: losing battles or winning the war?
por: Reperant, Leslie A., et al.
Publicado: (2020)

Spatial and Temporal Association of Outbreaks of H5N1 Influenza Virus Infection in Wild Birds with the 0°C Isotherm
por: Reperant, Leslie A., et al.
Publicado: (2010)

Influenza Virus Infections and Cellular Kinases
por: Meineke, Robert, et al.
Publicado: (2019)

Emerging viral infections in a rapidly changing world
por: Kuiken, Thijs, et al.
Publicado: (2003)

Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008
por: Dijkstra, Frederika, et al.
Publicado: (2011)

Reassortment between Avian H5N1 and Human Influenza Viruses Is Mainly Restricted to the Matrix and Neuraminidase Gene Segments
por: Schrauwen, Eefje J. A., et al.
Publicado: (2013)

Severe acute respiratory syndrome (SARS) vaccines
por: Haagmans, Bart L., et al.
Publicado: (2008)

The Importance of Understanding the Human–Animal Interface: From Early Hominins to Global Citizens
por: Reperant, Leslie A., et al.
Publicado: (2012)

Host Responses to Respiratory Syncytial Virus Infection
por: Agac, Ayse, et al.
Publicado: (2023)

Clearance of influenza virus from the lung depends on migratory langerin(+)CD11b(−) but not plasmacytoid dendritic cells
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2008)

Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis
por: Ramezanpour, Bahar, et al.
Publicado: (2015)

Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?
por: Wilken, Lucas, et al.
Publicado: (2020)

Response to 2009 Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Patients and the Influence of Prior Seasonal Influenza Vaccination
por: Soonawala, Darius, et al.
Publicado: (2011)

Both Conventional and Interferon Killer Dendritic Cells Have Antigen-Presenting Capacity during Influenza Virus Infection
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2009)

Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses
por: van de Sandt, Carolien E., et al.
Publicado: (2012)

Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 Virus
por: Bodewes, Rogier, et al.
Publicado: (2009)

Coronaviruses and their therapy
por: Haagmans, Bart L., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ehjtokhsc0394a6ta2e8eauk1d